Keywords: (â)-Cocaine hydrochloride (PubChem CID: 656832); (+)-methamphetamine hydrochloride (PubChem CID: 66124); haloperidol (PubChem CID: 3559); reserpine (PubChem CID: 5770); paroxetine hydrochloride hemihydrate (PubChem CID: 62878);
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Astrocytes; Sigma receptor; BDNF; Neurotrophin; In situ ELISA; 4-PPBP (PubChem CID: 3035672); (+)-SKF10047 (PubChem CID: 13286169); BD1063 (PubChem CID: 574780); NE-100 (PubChem CID: 9841596); Haloperidol (PubChem CID: 3559); Reduced haloperidol (PubChem
Keywords: BDNF; brain-derived neurotrophic factor; GAD67; glutamate decarboxylase 67; Haloperidol (PubChem CID: 3559); Mildronate (PubChem CID: 123868); Stress; Haloperidol; Memory; Protein expression; Mildronate;
Keywords: Bupropion (PubChem CID: 62884); Chlorpromazine HCl (PubChem CID: 6240); Fluphenazine 2HCl (PubChem CID: 67356); Spiperone (PubChem CID: 5265); Haloperidol (PubChem CID: 3559); Pimozide (PubChem CID: 16362); α-Methyl-p-tyrosine (PubChem CID: 3125); Reserpi
Effect of vinylpyrrolidone polymers on the solubility and supersaturation of drugs; a study using the Cheqsol method
Keywords: Bendroflumethiazide (PubChem CID: 2315); Bupivacaine hydrochloride (PubChem CID: 64737); Haloperidol (PubChem CID: 3559); Maprotiline hydrochloride (PubChem CID: 71478); Cyproheptadine hydrochloride (PubChem CID: 13770); Papaverine hydrochloride (PubChem
Optimization of maintenance therapy of Risperidone with CYP2D6 genetic polymorphisms through an extended translational framework-based prediction of target occupancies/clinical outcomes
Keywords: RO; receptor occupancy; EPS; extrapyramidal symptoms; PK; pharmacokinetic; PD; pharmacodynamic; EM; extensive metabolizer; IM; intermediate metabolizer; PM; poor metabolizer; PBPKPD; physiology-based pharmacokinetic and pharmacodynamic; P-gp; P-glycoprote
Pharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 2A inhibitor, PDM-631
Keywords: BAY 60-7550 (PubChem CID: 25273570); Donepezil (PubChem CID: 5741); EVP-6124 (PubChem CID: 46196517); Haloperidol (PubChem CID: 3559); Risperidone (PubChem CID: 5073); PDE2A; PDM-631; Cognition; Antipsychotics; Schizophrenia;
Induction of dopamine D1 and D5 receptors in R28Â cells by light exposures
Keywords: Dopamine receptors; R28Â cells; Ambient lighting; LED; light emitting diode; PCR; polymerase chain reaction; RT-PCR; reverse transcription - polymerase chain reaction; qPCR; quantitative polymerase chain reaction; DRD1; dopamine receptor D1; DRD2; dopamin
Specific prediction of clinical QT prolongation by kinetic image cytometry in human stem cell derived cardiomyocytes
Keywords: Fluo 4AM (PubChem CID: 4060965); Cisapride (PubChem CID: 2769); Dofetilide (PubChem CID: 71329); Droperidol (PubChem CID: 3168); Haloperidol (PubChem CID: 3559); Pimozide (PubChem CID: 16362); Quinidine (PubChem CID: 441074); Sematilide (PubChem CID: 5850
The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors
Keywords: LSD (PubChem CID: 5761); p-chlorophenylalanine (PubChem CID: 39972); Haloperidol (PubChem CID: 3559); MDL 100,907 (PubChem CID:60858); EPPTB (PubChem CID: 25175634); WAY 100,635 (PubChem CID: 5684); Apomorphine (PubChem CID: 6005); 8-OH-DPAT (PubChem CID: